You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for New Drug Application (NDA): 090872

✉ Email this page to a colleague

« Back to Dashboard

NDA 090872 describes SUMATRIPTAN AND NAPROXEN SODIUM, which is a drug marketed by Aurobindo Pharma Ltd, Rising, and Sun Pharm, and is included in three NDAs. It is available from three suppliers. Additional details are available on the SUMATRIPTAN AND NAPROXEN SODIUM profile page.

The generic ingredient in SUMATRIPTAN AND NAPROXEN SODIUM is naproxen sodium; sumatriptan succinate. There are forty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the naproxen sodium; sumatriptan succinate profile page.

Summary for 090872

Tradename:	SUMATRIPTAN AND NAPROXEN SODIUM
Applicant:	Rising
Ingredient:	naproxen sodium; sumatriptan succinate
Patents:	0

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	500MG;EQ 85MG BASE
Approval Date:	Sep 4, 2018	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.